If you are sick with the hepatitis B (HBV) virus, the only way to avoid the disease is to get vaccinated, says Dr. Bimal Raja, head of the department of gastroenterology at a hospital in New Delhi.
But for those who have already had the infection, the best treatment is to stay in close contact with their loved ones, including their spouses, children and pets.
Read more: How to prevent hepatitis B in IndiaThe Indian government has started vaccinating people against the HBV virus.
The country is one of the few countries in the world where the disease has not been completely eradicated.
It is estimated that nearly 90 percent of the country’s population still has HBV infection.
But if you are a member of the 1.1 million people who have hepatitis B infection in India, you should be aware of the risks.
Read more: The top three ways to avoid HBV in India: Dr. RajaRead moreHepatitis B is transmitted through blood transfusions, which can lead to blood clots.
There is no vaccine for HBV.
There are currently no antiviral medicines available.
A vaccine for the virus is not expected to be ready for commercialization in India until next year.
India’s healthcare system is also lacking.
In a country where there is no specific national health plan, it is very difficult to determine what will work best for a particular patient.
There has also been a lack of awareness among Indian patients about the importance of being vaccinated against HBV and other hepatitis B related diseases.
In a recent report published by the Institute of Science and Technology Policy Research (ITPPR), researchers from the University of Mumbai and IIT-Delhi examined the impact of HBV vaccination on the overall health of Indian patients.
They looked at how much more effective HBV vaccines are in the country than in the United States and the UK.
The study concluded that in India they achieved a significant improvement in survival rates and mortality, and a significant reduction in morbidity and mortality.
The researchers also discovered that vaccination programs are very effective in reducing the incidence of HB-related conditions, particularly hepatitis B. According to the report, a vaccination program reduces the incidence and mortality rate of hepatitis B by a factor of five.
Read the full report:India’s HBV vaccine program is not a perfect successThe Indian health system is very poor in terms of its provision of healthcare services and services, said Dr. Bhaskar Pandey, director of the IIT Medical School.
According the Indian Medical Council (IMC), there are about 13 million patients in India.
Many of these patients do not have the ability to get medical attention and therefore cannot be helped by medical professionals.
The Indian medical system has been operating under a severe budgetary crisis and there are not many medical providers.
India is also facing a massive HIV pandemic and there is a shortage of doctors and nurses.
It may take a decade for India to meet its healthcare needs.
The authors of the report noted that the lack of healthcare resources in India makes it difficult to provide timely treatment to patients.
“There is a high burden of care borne by patients and their families,” said Dr Pandey.
“The lack of effective healthcare delivery services, especially during the pandemic, makes it challenging for health systems to provide treatment to the sick and the dying.”
The report also showed that there is not enough money in the budget to provide basic healthcare services like hospitalization, vaccinations, immunizations and diagnostic tests.
In the case of immunizations, there is currently no vaccine available for the hepatitis virus.
In addition, the cost of treating hepatitis B is prohibitive.
The report concluded that the healthcare system needs to address these problems and develop a comprehensive healthcare system.
“Healthcare systems have to be restructured to improve patient care and access to healthcare services, and make use of all available resources to provide healthcare services,” said the report.